MARKET

TENX

TENX

Tenax Therapeutics Inc
NASDAQ
12.73
+0.37
+2.99%
After Hours: 12.72 -0.01 -0.08% 17:58 02/06 EST
OPEN
12.39
PREV CLOSE
12.36
HIGH
13.12
LOW
12.20
VOLUME
128.17K
TURNOVER
--
52 WEEK HIGH
18.38
52 WEEK LOW
4.630
MARKET CAP
79.48M
P/E (TTM)
-11.2735
1D
5D
1M
3M
1Y
5Y
1D
Tenax Therapeutics nimmt an Guggenheim Emerging Outlook Biotech Summit teil
Reuters · 4d ago
Weekly Report: what happened at TENX last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at TENX last week (0119-0123)?
Weekly Report · 01/26 10:04
Weekly Report: what happened at TENX last week (0112-0116)?
Weekly Report · 01/19 10:09
Weekly Report: what happened at TENX last week (0105-0109)?
Weekly Report · 01/12 10:09
Tenax Therapeutics Updates Chief Medical Officer Agreement
TipRanks · 01/09 22:03
Tenax Therapeutics Prorates CMO Salary for Reduced Work Schedule
Reuters · 01/09 21:34
Tenax Therapeutics: A Speculative Buy
Seeking Alpha · 01/09 06:51
More
About TENX
Tenax Therapeutics, Inc. is a Phase 3 development-stage pharmaceutical company. The Company is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The Company's products include TNX-201 (oral enteric-coated imatinib) and TNX-103 (oral levosimendan). The Company is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The Company’s other programs include TNX-101 and TNX-102. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. The Company has completed the Phase II trial of levosimendan in patients with PH and heart failure with preserved ejection fraction (HFpEF).

Webull offers Tenax Therapeutics Inc stock information, including NASDAQ: TENX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TENX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TENX stock methods without spending real money on the virtual paper trading platform.